Member Info for ShareBag

Anything can happen in aim yes but i very much doubt it. We have 1 mill rev in 2019 and projected minimum 4 mill this year. It didn’t take too long to reach 1 mill seen as though sales team only came in q3 2019. Would you hedge against another promised target? Its simply if you don’t think it will be reached wait if the sp dips further. The fact several if not most of the top 20 cosmetics companies are doing business with Integumen should speak for itself. You can either trade this stock or make an investment but for me this is one of them stocks that will do very well. 2020 is key and once we get to 4 mill - we can build on that. Also some of these companies will be using Integumen’s services over the coming months-and years for their different products. Sp dropping is a pain to see but it wont stay here for long. It is just an opportunity to add of one can.

If 4 mill is achieved and we are profitable by end by H1 this year of the Sp isn't well above 2 p then that will be a shocker.

That I didn’t pick more up and a rise on a price higher than todays would be nice but you can’t have everything. Here what we are playing for

oing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.

Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.

Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.

New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.

Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.

3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.

Have a 3 year development Remote Automated Water Research project for RAWTest. Watch out for the possible news with MWG as CEO Gerard B joins the board after successful placing from MWG. RAWTest has many other possible applications which can lead to driving additional revenue's.

I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.

Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.

Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.

May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.

Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.

4 mill will be reached. No reason why GB would have given that figure and set himself up for an Almighty fall but hey everyone has a reason to sell.

What i am saying is that the companies that use the services will probably not go out if their way to comment and the only way we would know if they are happy is from them putting down their money as form of multi year contracts and revenues across different product range.

I can’t remember who it was from the top of my head (have a feeling could have been loreal) but at a conference they did mention of Integumen’s service. This was approx 6 months ago not heard anything else though but would these companies come out and comment on Integumen’s services and if so which avenue would they use to mention anything?

If you can wait a few months. These chunky sells smells of placee’s getting rid and using the news and the bounce to 1.80. Once they clear it will stabilise and news shouldn’t be too long. Medium to long term, it should be interesting.

Doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.
 
Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.
 
Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.
 
New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.
 
Sales team only recruited in around End of June 2019 giving only  a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed  as CIO and both having a wealth of experience.
 
3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.
 
Have a 3 year development Remote Automated Water Research project for RAWTest. Watch out for the possible news with MWG as CEO Gerard B joins the board after successful placing from MWG. RAWTest has many other possible applications which can lead to driving additional revenue's.
 
I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and  RAWTest revenue's going forward.
 
Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.
 
Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.
 
May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.
 
Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.
 

Does seem to be order filling. Can sell 1.7 mill in one go

Only 70k but i am done for now. Prob got more than I originally wanted but it is for long term hold

The only offloading I am doing is in the karzi every morning like clock work.

Don't go by anyone on the board (even me) . But here’s a quick summary of what has been achieved so far as a starting point to your own research. No one can say they haven’t come a long way from 12 months ago. We are looking at a different beast now.

SKIN

Doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.

Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.

Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.

New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.

Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.

3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.

Have a 3 year development Remote Automated Water Research project for RAWTest. Watch out for the possible news with MWG as CEO Gerard B joins the board after successful placing from MWG. RAWTest has many other possible applications which can lead to driving additional revenue's.

I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.

Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.

Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.

May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.

Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound com

So we are to reach positive monthly cash flow and material contracts to drop. We wont need capital if as said we will grow organically and if we are signing up contracts already. Its floating around this range because PI’s want to see further revenue figures. AGM did not allow to raise more than the amount raised last December. As GB said they are managing growth in a way that will allow then to honour contracts and agreements and provide a excellent service for the clients. Last thing one wants is to try and acquire more than they can handle and fall on their arses and losing key clients who in all fairness will use Integumen’s service for possible years. Always get these guys talkinh about a riase. Most easiest thing to use scare investors. They have already raised and will they need to when they will be in positive cash flow come before end of H1 2020! If you think they will then don't buy but thanks for taking your time to comment and making others aware.

I am sure GB knows that if the forecasted target is not reached in 2020, it will be officially RNS'd - I am sure he wont have given that figure out if he didn't have it more or less in the bag or be at-least achievable.

And what doe sit matter if they did use the extra 180k before Integumen took over? They own Rinocloud don't they so they are entitled to do so as it was a year end figure? Clutching at straws to spread negativity imo.

Shandypants You are pointing out the fact that 178 k has been included when SkIn didn't own the company and you have made that point before. The fact is they still made 800k rev in 2019 which is a massive increase. You cannot please some people - the question is that if you are unsure of what Integumen are doing then why be here? 4 mill figure has been given in 2020 and if you do not believe this will happen then yes this stock is not for you? Yes we know the market is waiting or solid figures so the bottom line is what are you waiting for? If you are waiting or solid figures before getting in then that is fair enough - move on. You mentioning the point about being 800 k twice (that I know of) is suspect for me.

The important thing is we are building and are making use of existing pipe-lines with the calibrations. Short term yes it is frustrating but if you believe in the fundamentals then sit back and this we re-rate once we have solid figures. 1 million in 2019 is a start and now for the bigger revenue details in 2020. The investor evenings is a good chance to meet the guys who are running Integumen and imo doing a good job from what we have seen. Jumping around stocks is not for me and I am willing to wait it out to see this company flourish.

Happy with that news - patience is key

Well said. Just the daily movements but the trolls come out on Advfn when they smell blood. They have been quiet last few days.

Some are talking about MWG a fair bit but the fact is we are doing more than ok without whatever comes out of RawTEST. We have many string to the bow. LABSKIN AI, Rino Cloud/Drive, Woundcare, Partnership with PTY, opening doors to provide a Cloud service to potential over 150+ clients blah blah blah. Patience is what makes money as-long as you do the research :). It does look to be place's exiting but the SP is holding somewhat from 1.5 placing price.

In one go today. Short term fluctuations - The stock price does not always travel in one line up. Look at the fundamentals, the product and the target market. DYOR